Periodontal disease: the influence of metabolic syndrome

Nutrition & Metabolism

Giuseppe Marzo³  Simona Tecco³  Alberto Baldini¹  Stefano Tetè²  Roberto Gatto³  Stefano Mummolo³  Laura Procaccini³  Annalisa Monaco³  Enrico Marchetti³ 

[1] Department of Oral Science, University of Tor Vergata, Rome, Italy;Department of Oral Science, Nano and Biotechnology, University of Chieti, Chieti, Italy;Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy

关键词: Periodontitis;    Adipocytokines;    Metabolic syndrome;    Oxidative stress;   

Others  :  811961
DOI  :  10.1186/1743-7075-9-88

 received in 2012-01-08, accepted in 2012-08-27,  发布年份 2012

【 摘 要 】

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors that include obesity, impaired glucose tolerance or diabetes, hyperinsulinemia, hypertension, and dyslipidemia. Recently, more attention has been reserved to the correlation between periodontitis and systemic health. MetS is characterized by oxidative stress, a condition in which the equilibrium between the production and the inactivation of reactive oxygen species (ROS) becomes disrupted. ROS have an essential role in a variety of physiological systems, but under a condition of oxidative stress, they contribute to cellular dysfunction and damage. Oxidative stress may act as a common link to explain the relationship between each component of MetS and periodontitis. All those conditions show increased serum levels of products derived from oxidative damage, promoting a proinflammatory state. Moreover, adipocytokines, produced by the fat cells of fat tissue, might modulate the balance between oxidant and antioxidant activities. An increased caloric intake involves a higher metabolic activity, which results in an increased production of ROS, inducing insulin resistance. At the same time, obese patients require more insulin to maintain blood glucose homeostasis – a state known as hyperinsulinemia, a condition that can evolve into type 2 diabetes. Oxidation products can increase neutrophil adhesion and chemotaxis, thus favoring oxidative damage. Hyperglycemia and an oxidizing state promote the genesis of advanced glycation end-products, which could also be implicated in the degeneration and damage of periodontal tissue. Thus, MetS, the whole of interconnected factors, presents systemic and local manifestations, such as cardiovascular disease and periodontitis, related by a common factor known as oxidative stress.

【 授权许可】

   
2012 Marchetti et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Andriankaja OM, Sreenivasa S, Dunford R, DeNardin E: Association beteen metabolic syndrome and periodontal disease. Aust Dent J 2010, 55:252-259.
• [2]Armitage GC: Diagnosis of periodontal disease. J periodontology 2003, 74:1237-1247.
• [3]Zadik Y, Bechor R, Shochat Z, Galor S: Ethnic origin and alveolar bone loss in Israeli adults. Refuat Hapeh Vehashinayim 2008, 25(2):19-22.
• [4]The American Academy of Periodontology: Proceedings of the World Workshop in Clinical Periodontics. The American Academy of Periodontology, Chicago; 1989:I/23-I/24.
• [5]Ammons WF, Schectman LR, Page RC: Host tissue response in chronic periodontal disease. 1. The normal periodontium and clinical manifestations of dental and periodontal disease in the marmoset. J Periodontal Res 1972, 7(2):131-143.
• [6]Page RC, Schroeder HE: Pathogenesis of inflammatory periodontal disease. A summary of current work. Laboratory investigation; a journal of technical methods and pathology 1976, 34(3):235-249.
• [7]Sambunjak D, Nickerson JW, Poklepovic T, Johnson TM, Imai P, Tugwell P, Worthington HV: Flossing for the management of periodontal diseases and dental caries in adults. In Johnson, Trevor M. Cochrane Database Syst Rev 2011, 7(12):CD008829.
• [8]Hasturk H, Nunn M, Warbington M, Van Dyke TE: Efficacy of a Fluoridated Hydrogen Peroxide-Based Mouthrinse for the Treatment of Gingivitis: A Randomized Clinical Trial. J Periodontol 2004, 75(1):57-65.
• [9]Di Paola R, Briguglio F, Paterniti I, Mazzon E, Oteri G, Militi D, Cordasco G, Cuzzocrea S: Emerging role of PPAR-β/δ in inflammatory process associated to experimental periodontitis. Mediators Inflamm 2011, 7:87-159.
• [10]Dutzan N, Vernal R, Vaque JP, García-Sesnich J, Hernandez M, Abusleme L, Dezerega A, Gutkind JS, Gamonal J: Interleukin-21 Expression and its Association with Pro-Inflammatory Cytokines in Untreated Chronic Periodontitis Patients. J Periodontol 2012, 83(7):948-954.
• [11]Souza PP, Palmqvist P, Lundberg P, Lundgren I, Hänström L, Souza JA, Conaway HH, Lerner UH: Interleukin-4 and interleukin-13 inhibit the expression of leukemia inhibitory factor and interleukin-11 in fibroblasts. Mol Immunol 2012, 49(4):601-610.
• [12]Reaven GM, Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1998, 37:1595-1607.
• [13]Abhishek G, Gupta V: Metabolic Syndrome: what are risks for humans? BioScience Trend 2010, 4:204-212.
• [14]Aquilante CL, Kosmiski LA, Knusten SD, Zineh I: Relationship between plasma resistin concentrations, inflammatory chemokines and components of the Metabolic Syndrome in adults. Metabolism 2008, 5(Suppl 4):494-501.
• [15]Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001, 285(19):2486-2497.
• [16]Metabolic Syndrome.  ,  ;  . http://www.heart.org/HEARTORG/Conditions/More/MetabolicSyndrome/About-Metabolic-Syndrome_UCM_301920_Article.jsp webcite
• [17]Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M: Metabolic Syndrome and Periodontitis: Is Oxidative Stress a Common Link? J Dent Res 2009, 88:503-518.
• [18]Kahn R: Metabolic syndrome: what is the clinical usefulness? Lancet 2008, 371:1891-1893.
• [19]Reaven GM: The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006, 83:1237-1247. erratum in Am J Clin Nutr 2006, 84:1253
• [20]Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004, 24(Suppl5):816-823.
• [21]Iain LC C, Matthews JB: The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2007, 43:160-232.
• [22]Sgolastra F, Petrucci A, Gatto R, Monaco A: Efficacy of Er:YAG laser in the treatment of chronic periodontitis: systematic review and meta-analysis. Lasers Med Sci 2011, 27(3):661-673.
• [23]Halliwell B, Gutteridge JMC, Cross CE: Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 1992, 119:598-617.
• [24]Armutcu F, Ataymen M, Atmaca H, Gurel A: Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem Lab Med 2008, 46(Suppl 6):785-790.
• [25]Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL: Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001, 50(Suppl 1):159-165.
• [26]Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL: Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 2001, 50:404-410.
• [27]Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, et al.: Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004, 89:4963-4971.
• [28]Sharma P, Mishra S, Ajmera P, Mathur S: Oxidative stress in metabolic syndrome. Indian J Clin Biochem 2005, 20:145-149.
• [29]Di Filippo C, Verza M, Coppola L, Rossi F, D’Amico M, Marfella R: Insulin resistance and postprandial hyperglycemia the bad companionsin natural history of diabetes: effects on health of vascular tree. Curr Diabetes Rev 2007, 3:268-273.
• [30]Tilg H, Moschen AR: Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008, 14:222-231.
• [31]Bruce CR, Carey AL, Hawley JA, Febbraio MA: Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Diabetes 2003, 52:2338-2345.
• [32]Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, et al.: Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:2587-2593.
• [33]Soory M: A Role for Non-Antimicrobial Actions of Tetracyclines in Combating Oxidative Stress in Periodontal and Metabolic Diseases: A Literature Review. The Open Dentistry Journal 2008, 2:5-12.
• [34]Sapadin AN, Fleischmajer R: Tetracyclines: Non antibiotic properties and their implications. J Am Acad Dermatol 2006, 54:258-265.
• [35]Tilakaratne A, Soory M: Osteoblastic responses to LPS, glucose-oxidised LDL and minocycline: therapeutic targets for periodontal and cardiometabolic diseases. Recent Pat Endocr Metab Immune Drug Discov 2012, 6(1):73-84.
• [36]Brilhante Wolle CF, de Aguiar Zollmann L, Etges A, Vitalis GS, Leite CE, Campos MM: Effects of the antioxidant agent tempol on periapical lesions in rats with doxorubicin-induced cardiomyopathy. J Endod 2012, 38(2):191-195.
• [37]Ryu EY, Park SY, Kim SG, da Park J, Kang JS, Kim YH, Seetharaman R, Choi YW, Lee SJ: Anti-inflammatory effect of heme oxygenase-1 toward Porphyromonas gingivalis lipopolysaccharide in macrophages exposed to gomisins A, G, and J. J Med Food 2011, 14(12):1519-1526.
• [38]Feghali K, Feldman M, La VD, Santos J, Grenier D: Cranberry Proanthocyanidins: Natural Weapons against Periodontal Diseases. J Agric Food Chem 2011, 29: .
• [39]Ozdemir H, Kara MI, Erciyas K, Ozer H, Ay S: Preventive effects of thymoquinone in a rat periodontitis model: a morphometric and histopathological study. J Periodontal Res 2012, 47(1):74-80.
• [40]de Menezes AM, de Souza GF, Gomes AS, de Carvalho Leitão RF, de Albuquerque Ribeiro R, de Oliveira MG, de Castro Brito GA: S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats. J Periodontol 2012, 83(4):514-521.
• [41]Park SY, da Park J, Kim YH, Kim Y, Choi YW, Lee SJ: Schisandra chinensis α-iso-cubebenol induces heme oxygenase-1 expression through PI3K/Akt and Nrf2 signaling and has anti-inflammatory activity in Porphyromonas gingivalis lipopolysaccharide-stimulated macrophages. Int Immunopharmacol 2011, 11(11):1907-1915.
• [42]Bjelland S, Bray P, Gupta N, et al.: Dentists, diabetes and periodontitis. Austr Dent Journ 2002, 47:202-207.
• [43]Mustapha IZ, Debrey S, Oladubu M, Ugarte R: Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol 2007, 78(12):2289-2302.
• [44]Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al.: The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001, 72:774-778.
• [45]Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al.: Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997, 68:713-719.
• [46]Pietropaoli D, Tatone C, D’Alessandro , Monaco A: Possible involment of advanced glycation end products in periodontal diseases. B Int Journ of immunopathol and pharmacol 2010, 23(Suppl 3):683-691.
• [47]Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW: Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 2005, 32:40-44.
• [48]Bohlender JM, Franke S, Stein G, Wolf G: Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005, 289:F645-F659.
• [49]Wong RK, Pettit AI, Quinn PA, et al.: Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation 2003, 108:1858-1864.
• [50]Preshaw PM, Alba AL, Herrera D, et al.: Periodontitis and diabetes: a two way relationship. Diabetologia 2012, 55:21-31.
• [51]Allen EM, Mattews JB, O’Halloran DJ, et al.: Oxidative and inflammatory status in type 2 diabetes patients with periodontitis. J Clin Peridontol 2011, 38:894-901.
• [52]Amir J, Waite M, et al.: The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity. Cell Immunol 2011, 272:45-52.
• [53]Hwang JT, Kim SH, Hur HJ, Kim HJ, Park JH, Sung MJ, Yang HJ, Ryu SY, Kim YS, Cha MR, Kim MS, Kwon DY: Decursin, an Active Compound Isolated from Angelica gigas, Inhibits Fat Accumulation, Reduces Adipocytokine Secretion and Improves Glucose Tolerance in Mice Fed a High-Fat Diet. Phytother Res 2012, 26(5):633-638.
• [54]D’Aiuto F, Nibali L, Parkar M, Patel K, et al.: Oxidative stress, systemic inflammation and severe periodontitis. J Dent Res 2010, 89:1241-1246.
• [55]Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003, 52:1-8.
• [56]D’Aiuto F, Parkar M, Andreou G, et al.: Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004, 83:156-160.
• [57]Behle JH, Sedaghatfar MH, Demmer RT, et al.: Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009, 36:287-294.
• [58]D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS: Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005, 84:269-273.
• [59]Offenbacher S, Beck JD, Moss K, et al.: Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009, 80:190-201.
• [60]Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A: Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 2007, 34:835-843.
• [61]Offenbacher S, Madianos PN, Champagne CM, Southerland JH, Paquette DW, Williams RC, et al.: Periodontitis-atherosclerosis syndrome: an expanded model of pathogenesis. J Periodont Res 1999, 34:346-352.
• [62]Libby P, Ridker P, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
• [63]López NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, López R: Effects of Periodontal Therapy on Systemic Markers of Inflammation in Patients With Metabolic Syndrome: A Controlled Clinical Trial. J Periodontol 2012, 83(3):267-278.
• [64]Pischon N, Heng JP, et al.: Obesity, inflammation and periodontal disease. J Dent Res 2007, 86(suppl. 5):400-409.
• [65]El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet induced obesity. J Clin Invest 2000, 105:1827-1832.
• [66]Nishimura F, Murayama Y: Periodontal inflammation and Insulin resistance, lessons from obesity. J Dent Res 2001, 80((suppl.8):1690-1694.
• [67]Hotamisligil GS, Amer P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-at in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415.
• [68]Lundholm K, Holm G, Schersten T: Insulin resistance in patients with cancer. Cancer Res 1997, 38:4665-4670.
• [69]Rotter V, Nagaev I, Smith U: Interleukin-6 (IL-6) induces insulin resistance in 3 T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003, 278:45777-45784.
• [70]Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-at function. Nature  , 389:610-614.
• [71]Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, et al.: Insulin/IGF-1 and TNF-ot stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 2001, 107:181-189.
• [72]Hansen LL, Ikeda Y, Olsen GS, Busch AK, Mosthaaf L: Insulin signaling is inhibited by micromolar concentrations of H202. Evidence for a role of H202 in tumor necrosis factor a-mediated insulin resistance. J Biol Chem 1999, 274:25078-25084.
• [73]Merchant AT, Pitiphat W, Rimm EB, Joshipura K: Increased physical activity decreases periodontitis risk in men. Eur J Epidemiol 2003, 18:891-898.
• [74]Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB: Leisure-time physical activity and reduced plasma levels of obesityrelated inflammatory markers. Obes Res 2003, 11:1055-1064.
• [75]Al-Zahrani MS, Borawski EA, Bissada NF: Periodontitis and three health-enhancing behaviors: maintaining normal weight, engaging in recommended level of exercise, and consuming a high-quality diet. J Periodontol 2005, 76:1362-1366.
• [76]McDevitt MJ, Wang HY, Knobelman C, et al.: Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontology 2000, 71:156-163.
• [77]Bawadi HA, Khader YS, Haroun TF, Al-Omari M, Tayyem RF: The association between periodontal disease, physical activity and healthy diet among adults in Jordan. J Periodontal Res 2011, 46(1):74-81.
• [78]Beck JD, Offenbacher S: Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005, 76(Suppl11):2089-2100.
• [79]Loos BG: Systemic markers of inflammation in periodontitis. J Periodontol 2005, 76(Suppl11):2106-2115.
• [80]Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M: Periodontal treatment decreases plasma oxidized LDL level and oxidative stress. Clin Oral Investig 2011, 15(6):953-958.
• [81]Furugen R, Hayashida H, Yamaguchi N, Yoshihara A, Ogawa H, Miyazaki H, et al.: The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Clin Periodontol 2008, 43:556-562.
• [82]Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, et al.: Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res 2008, 87:319-322.
• [83]Bozkurt FY, Yetkin Ay Z, Sutcu R, Delibaş N, Demirel R: Gingival crevicular fluid leptin levels in periodontitis patients with long-term and heavy smoking. J Periodontol 2006, 77:634-640.
• [84]Chaffee BW, Weston SJ: Association between chronic periodontal disease and obesity: a systematic review an meta-analysis. J Periodontol 2010, 12:1708-1724.
• [85]Lakkis D, Bissada NF, Saber A, Khaitan L, Palomo L, Narendran S, Al-Zahrani MS: Response to Periodontal Therapy in Subjects Who Had Weight Loss Following Bariatric Surgery and Obese Counterparts: A Pilot Study. J Periodontol 2011, 83(6):684-689.
• [86]Zouza EP, Barroso EM, et al.: The role of obesity as a modifying factor in patients undergoing non-surgical periodontal therapy. J Periodontol 2010, 82:676-682.
• [87]Suvan J, D’Aiuto F, Moles DR, Petrie A, Donos N: Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev 2011, 12(5):e381-e404.
• [88]Kampe J, Stefanidis A, Lockie SH, Brown WA, Dixon JB, Odoi A, Spencer SJ, Raven J, Oldfield BJ: Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model. Int J Obes (Lond) 2012, 27: .
• [89]Baltazi M, Katsiki N, Savopoulos C, Iliadis F, Koliakos G, Hatzitolios AI: Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study. Am J Cardiovasc Dis 2011, 1(1):48-59.
• [90]Chu SH, Lee MK, Ahn KY, Im JA, Park MS, Lee DC, Jeon JY, Lee JW: Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One 2012, 7(4):e34710.
• [91]Gerrits AJ, Gitz E, Koekman CA, Visseren FL, van Haeften TW, Akkerman JW: Induction of insulin resistance by the adipokines resistin, leptin, PAI-1 and RBP4 in human megakaryocytes. Haematologica 2012, 97(8):1149-1157.
• [92]Ross Middleton KM, Patidar SM, Perri MG: The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 2011, 13(6):509-517.
• [93]Huck O, Tenenbaum H, Davideau JL: Relationship between Periodontal Diseases and Preterm Birth: Recent Epidemiological and Biological Data. J Pregnancy 2011, 16:46-54.
• [94]Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G, Redon J: Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 2007, 21(suppl.1):68-75.
• [95]Chaves FJ, Mansego ML, Blesa S, Gonzalez-Albert V, Jimenez J, Tormos MC, Espinosa O, Giner V, Iradi A, Saez G, Redon J: Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 2007, 20(supp 1):62-69.
• [96]Scott CL: Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol 2003, 92:35i-42i.
• [97]Arthur H, Friedlander DMD, Jane Weinreb MD: Metabolic syndrome: pathogenesis, medical care and dental implications. Clinical pactice 2007, 138:179-187.
• [98]Angeli F, Verdecchia P, Pellegrino C, Pellegrino RG, Pellegrino G, Prosciutti L, et al.: Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension 2003, 41:488-492.
• [99]Rivas-Tumanyan S, Spiegelman D, Curhan GC, Forman JP, Joshipura KJ: Periodontal disease and Incidence of Hypertension in the Health Professionals Follow-Up Study. Am J Hypertens 2012, 25(7):770-776.
• [100]Rivas-Tumanyan S, Campos M, Zevallos JC, Joshipura KJ: Periodontal Disease, Hypertension and Blood Pressure Among Older Adults in Puerto Rico. J Periodontol 2012,  : .
• [101]Higashi Y, Goto C, Jitsuiki D, Umemura T, Nishioka K, Hidaka T, Takemoto H, Nakamura S, Soga J, Chayama K, Yoshizumi M, Taguchi A: Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension 2008, 51(2):446-453.
• [102]Chapple IL, Brock GR, Milaward MR, et al.: Compromised GCF total antioxidant capacity in periodontitis. Cause or effect? J Clin Periodontol 2007, 34:103-110.
• [103]Brock GR, Matthews JB, Butterworth CJ, Chapple ILC: Local and systemic antioxidant capacity in periodontitis and health. J Clin Periodontol 2004, 31:515-521.
• [104]Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C: Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 2004, 31:25-29.
• [105]Borges I Jr, Moreira EA, Filho DW, de Oliveira TB, da Silva MB, Fröde TS: Proinflammatory and oxidative stress markers in patients with periodontal disease. Mediators Inflamm 2007, 4:57-94.
• [106]Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al.: Advanced glycation endproducts stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007, 40:345-353.
• [107]Vilela EM, Bastos JA, Fernandes N, Ferreira AP, Chaoubah A, Bastos MG: Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo) 2011, 66:657-662.
• [108]Tonetti MS, D Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al.: Treatment of periodontitis and endothelial function. N Engl J Med 2007, 356:911-920.
• [109]Chaffee BW, Wetson SJ: Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol 2010, 81:1708-1724.
• [110]Timonen P, Niskanen M, Suominen-Taipale L, et al.: Metabolic syndrome, periodontal infection and dental caries. J Dent Res 2010, 89:1068-1073.
• [111]Jenkins DJ, Wolever TM, Taylor RH, et al.: Glycemix index of foods:a physiological basis for carbohydrate exachange. Am J Clin Nutr 1981, 34:362-366.
• [112]Ludvig DS: The glycemic index: physiological mechanisms relating to obesity, diabetes and cardiovascular disease. JAMA 2002, 287:2414-2423.
• [113]Janket S-J, Jones JA, Meurman JH, Baird AE, Van Dyke TE: Oral Infection, hyperglycemia and endothelial dysfunction. Oral Surg, Oral Med, Oral Pathol, Oral Radiol and Endodontology 2008, 105(suppl 2):173-179.
• [114]Brotman DJ: Effects of counterregulatory hormones in a high glycemic index diet. JAMA 2002, 14(6):288-695.
• [115]Liu S, Manson JE: Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease. Curr Opin Lipidol 2001, 12:395-404.
• [116]Nowjack-Raymer RE, Sheiham A: Association of edentulism and diet and nutrition in US adults. J Dent Res 2003, 82:123-126.
• [117]Ritchie CS, Joshipura K, Hung HC, Douglass CW: Nutrition as a mediator in the relation between oral and systemic disease: associations between specific measures of adult oral health and nutrition outcomes. Crit Rev Oral Biol Med 2002, 13:291-300.
• [118]Krall E, Hayes C, Garcia R: How dentition status and masticatory function affect nutrient intake. JADA 1998, 129:1261-1269.
• [119]Morais JA, Heydecke G, Pawliuk J, Lund JP, Feine JS: The effects of mandibular two-implant overdentures on nutrition in elderly edentulous individuals. J Dent Res 2003, 82:53-58.
• [120]Wynn RL, Meiller TF, Crossley HL: Drug information for dentistry: Oral medicine for medically-compromised patients and specific oral conditions. 9th edition. Lexi-Comp, Hudson, Ohio; 2003.
• [121]Burger W, Chemnitius JM, Kneissl GD, Rucker G: Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuatio: review and meta-analysis. J Intern Med 2005B, 257:399-414.
• [122]Vernillo AT: Diabetes mellitus: relevance to dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:263-270.
• [123]Vernillo AT: Dental considerations for the treatment of patients with diabetes mellitus. JADA 2003, 134:24s-33s.